DNA damage, mutagenesis and cancer

AK Basu - International journal of molecular sciences, 2018 - mdpi.com
A large number of chemicals and several physical agents, such as UV light and γ-radiation,
have been associated with the etiology of human cancer. Generation of DNA damage (also …

[HTML][HTML] BRAF mutant colorectal cancer: prognosis, treatment, and new perspectives

E Sanz-Garcia, G Argiles, E Elez, J Tabernero - Annals of Oncology, 2017 - Elsevier
The MAPK cascade plays a crucial role in tumor cell proliferation and survival. Accumulating
evidence suggests that mutations in the BRAF oncogene are not only associated with poor …

[HTML][HTML] Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: pooled analysis of the CRYSTAL and OPUS …

C Bokemeyer, E Van Cutsem, P Rougier… - European journal of …, 2012 - Elsevier
BACKGROUND: The CRYSTAL and OPUS randomised clinical trials demonstrated that
adding cetuximab to first-line chemotherapy in patients with KRAS wild-type metastatic …

Mutational analysis of circulating tumor cells using a novel microfluidic collection device and qPCR assay

W Harb, A Fan, T Tran, DC Danila, D Keys… - Translational …, 2013 - Elsevier
Circulating tumor cells (CTCs) provide a readily accessible source of tumor material from
patients with cancer. Molecular profiling of these rare cells can lead to insight on disease …

[HTML][HTML] Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of …

L Licitra, R Mesia, F Rivera, E Remenar, R Hitt… - Annals of …, 2011 - Elsevier
Abstract Background The phase III EXTREME study demonstrated that combining cetuximab
with platinum/5-fluorouracil (5-FU) significantly improved overall survival in the first-line …

Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study

KJ O'Byrne, U Gatzemeier, I Bondarenko… - The lancet …, 2011 - thelancet.com
Background Findings from the phase 3 FLEX study showed that the addition of cetuximab to
cisplatin and vinorelbine significantly improved overall survival, compared with cisplatin and …

A let-7 microRNA-binding site polymorphism in the KRAS 3′ UTR is associated with reduced survival in oral cancers

BC Christensen, BJ Moyer, M Avissar… - …, 2009 - academic.oup.com
MicroRNA (miRNA)-binding site polymorphisms that could contribute to disease risk and
prognosis are rapidly being identified and investigated as this genetic variation may have a …

Current challenges and clinical investigations of epidermal growth factor receptor (EGFR)-and ErbB family-targeted agents in the treatment of head and neck …

RB Cohen - Cancer treatment reviews, 2014 - Elsevier
Overexpression of the epidermal growth factor receptor (EGFR) is a common characteristic
of head and neck squamous cell carcinomas (HNSCC). Cetuximab is a chimeric anti-EGFR …

Targeting loss of heterozygosity: a novel paradigm for cancer therapy

X Zhang, T Sjöblom - Pharmaceuticals, 2021 - mdpi.com
Loss of heterozygosity (LOH) is a common genetic event in the development of cancer. In
certain tumor types, LOH can affect more than 20% of the genome, entailing loss of allelic …

Radiomics and radiogenomics in evaluation of colorectal cancer liver metastasis

Y Wang, LY Ma, XP Yin, BL Gao - Frontiers in Oncology, 2022 - frontiersin.org
Colorectal cancer is one common digestive malignancy, and the most common approach of
blood metastasis of colorectal cancer is through the portal vein system to the liver. Early …